Stocks TTAM Financial statements
Financial statementsTitan America SA financial statements
Income statement, balance sheet and cash flow statement for the last 4 fiscal years, taken from the XBRL data Titan America SA files with the SEC in its annual reports.
In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.
Income statement
| FY2022 | FY2024 | FY2024 | FY2025 | |
|---|---|---|---|---|
| Revenue | 1,364 | 1,592 | 1,634 | 1,664 |
| Cost of revenue | 1,143 | 1,228 | 1,218 | 1,229 |
| Gross profit | 221 | 363 | 417 | 435 |
| Selling and marketing | 29.9 | 31 | 33.6 | 34.3 |
| Operating income | 97 | 226 | 251 | 268 |
| Interest expense | 19.1 | 22.2 | 26.2 | 22.6 |
| Interest income | 0.44 | 0.95 | 1.47 | 5.77 |
| Pre-tax income | 79.7 | 202 | 224 | 245 |
| Income tax | 17 | 47.1 | 57.5 | 59.4 |
| Net income | 62.7 | 155 | 166 | 185 |
| EBITDA | 185 | 317 | 351 | 377 |
| EPS, basic | 0.36 | 0.89 | 0.95 | 1.01 |
| EPS, diluted | 0.36 | 0.89 | 0.95 | 1.01 |
Balance sheet
| FY2022 | FY2024 | FY2024 | FY2025 | |
|---|---|---|---|---|
| Cash and equivalents | 29.8 | 22 | 12.1 | 212 |
| Inventory | 190 | 228 | 226 | |
| Total current assets | 373 | 384 | 610 | |
| Property, plant and equipment | 748 | 801 | 852 | 930 |
| Lease right-of-use assets | 61.4 | 64.7 | 66.2 | |
| Goodwill | 222 | 222 | 222 | |
| Intangible assets | 36 | 33.2 | 30.2 | 29 |
| Total assets | 1,499 | 1,566 | 1,894 | |
| Accounts payable | 151 | 140 | 131 | |
| Total current liabilities | 492 | 239 | 201 | |
| Lease liabilities | 53.7 | 56 | 55.4 | |
| Total liabilities | 779 | 816 | 860 | |
| Paid-in capital | 169 | 852 | 866 | |
| Retained earnings | 519 | 597 | 778 | |
| Total equity | 593 | 720 | 750 | 1,034 |
| Total liabilities and equity | 1,499 | 1,566 | 1,894 |
Cash flow statement
| FY2022 | FY2024 | FY2024 | FY2025 | |
|---|---|---|---|---|
| Net income | 62.7 | 155 | 166 | 185 |
| Depreciation and amortization | 87.7 | 91.1 | 99.9 | 109 |
| Cash from operations | 178 | 227 | 248 | 295 |
| Capital expenditures | -125 | -117 | -135 | -161 |
| Cash from investing | -127 | -118 | -136 | -152 |
| Debt issued | 95.2 | 45.5 | 85.2 | 0 |
| Debt repaid | -96.7 | -37.8 | -39.7 | -21.1 |
| Stock issued | 0 | 0 | 144 | |
| Share buybacks | 0 | 0 | -51.6 | 0 |
| Dividends paid | 0 | -33.8 | -85.1 | 0 |
| Cash from financing | -21.7 | -118 | -123 | 56.4 |
| Exchange rate effect | 0.23 | 0.5 | 1.18 | 0 |
| Free cash flow | 53 | 110 | 113 | 135 |
| Income taxes paid | 5.31 | 53.1 | 67.9 | 55.5 |
Key metrics
Profitability
| Metric | Value | How it is calculated |
|---|---|---|
| Gross margin | 26.1% | Gross profit / revenue. |
| Operating margin | 16.1% | Operating income / revenue. |
| EBITDA margin | 22.6% | EBITDA (operating income + depreciation and amortization) / revenue. |
| Pre-tax margin | 14.7% | Pre-tax income / revenue. |
| Net margin | 11.1% | Net income / revenue. |
| FCF margin | 8.1% | Free cash flow (cash from operations - capital expenditures) / revenue. |
| Operating cash flow margin | 17.8% | Cash from operations / revenue. |
| Effective tax rate | 24.3% | Income tax / pre-tax income, when pre-tax income is positive. |
| Return on assets (ROA) | 10.7% | Net income / average total assets. |
| Capex / revenue | 9.6% | Capital expenditures / revenue. |
| D&A / revenue | 6.5% | Depreciation and amortization / revenue. |
Growth
| Metric | Value | How it is calculated |
|---|---|---|
| Revenue growth, 1y | 1.8% | Revenue vs the same period a year earlier. Only from a positive base. |
| Revenue CAGR, 3y | 6.9% | Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Gross profit growth, 1y | 4.4% | Gross profit vs the same period a year earlier. Only from a positive base. |
| Gross profit CAGR, 3y | 25.3% | Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Operating income growth, 1y | 6.7% | Operating income vs the same period a year earlier. Only from a positive base. |
| Operating income CAGR, 3y | 40.3% | Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| EBITDA growth, 1y | 7.3% | EBITDA vs the same period a year earlier. Only from a positive base. |
| EBITDA CAGR, 3y | 26.8% | Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Net income growth, 1y | 11.7% | Net income vs the same period a year earlier. Only from a positive base. |
| Net income CAGR, 3y | 43.5% | Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| EPS growth, 1y | 6.3% | EPS vs the same period a year earlier. Only from a positive base. |
| EPS CAGR, 3y | 41.0% | Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Operating cash flow growth, 1y | 19.1% | Operating cash flow vs the same period a year earlier. Only from a positive base. |
| Operating cash flow CAGR, 3y | 18.3% | Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Free cash flow growth, 1y | 19.8% | Free cash flow vs the same period a year earlier. Only from a positive base. |
| Free cash flow CAGR, 3y | 36.5% | Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Total assets growth, 1y | 20.9% | Total assets vs the same period a year earlier. Only from a positive base. |
Balance sheet health
| Metric | Value | How it is calculated |
|---|---|---|
| Current ratio | 3.03x | Current assets / current liabilities. |
| Quick ratio | 1.05x | (Cash + short-term investments + receivables) / current liabilities. |
| Cash ratio | 1.05x | (Cash + short-term investments) / current liabilities. |
| Liabilities / assets | 45.4% | Total liabilities / total assets. |
| Interest coverage | 11.9x | Operating income / interest expense. |
| Working capital | $408.7M | Current assets - current liabilities. |
| Goodwill and intangibles / assets | 13.2% | (Goodwill + intangible assets) / total assets. |
Efficiency
| Metric | Value | How it is calculated |
|---|---|---|
| Asset turnover | 0.96x | Revenue / average total assets. |
| Fixed asset turnover | 1.87x | Revenue / average property, plant and equipment. |
| Inventory turnover | 5.41x | Cost of revenue / average inventory. |
| Days inventory | 67 days | 365 x average inventory / cost of revenue. |
| Days payables | 40 days | 365 x average accounts payable / cost of revenue. |
| FCF conversion | 72.7% | Free cash flow / net income, when net income is positive. |
| Capex / operating cash flow | 54.3% | Capital expenditures / cash from operations, when that is positive. |
Per share
| Metric | Value | How it is calculated |
|---|---|---|
| EPS, diluted | $1.01 | Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS. |
| EPS, basic | $1.01 | Net income per basic share, as reported (split-adjusted). |
| Payout ratio | 0.0% | Dividends paid / net income, when net income is positive. |
| Dividends / FCF | 0.0% | Dividends paid / free cash flow, when free cash flow is positive. |
| Buybacks / FCF | 0.0% | Share buybacks / free cash flow, when free cash flow is positive. |
Valuation
| Metric | Value | How it is calculated |
|---|---|---|
| Market cap | $2.55B | Share price x shares outstanding. |
| Enterprise value | $2.34B | Market cap + total debt - cash - short-term investments. |
| P/E | 13.8x | Market cap / net income. Only when net income is positive. |
| P/S | 1.53x | Market cap / revenue. |
| P/FCF | 18.9x | Market cap / free cash flow. Only when free cash flow is positive. |
| P/OCF | 8.64x | Market cap / cash from operations, when positive. |
| EV/Sales | 1.41x | Enterprise value / revenue. |
| EV/EBIT | 8.73x | Enterprise value / operating income, when both are positive. |
| EV/EBITDA | 6.21x | Enterprise value / EBITDA, when both are positive. |
| EV/FCF | 17.4x | Enterprise value / free cash flow, when both are positive. |
| FCF yield | 5.3% | Free cash flow / market cap. |
| Earnings yield | 7.3% | Net income / market cap (the inverse of P/E). |
| Dividend yield | 0.0% | Dividends paid over the period / market cap. |
| Shareholder yield | 0.0% | (Dividends paid + share buybacks) / market cap. |
| PEG | 0.34x | P/E / EPS growth per year over 3 years (in percent). Only when both are positive. |
What was Titan America SA's revenue in fiscal 2025?
Titan America SA reported revenue of $1.66B for fiscal 2025, 1.8% higher than the year before.
Was Titan America SA profitable in fiscal 2025?
Yes. Net income was $185.4M, a net margin of 11.1%.
How much free cash flow did Titan America SA generate in fiscal 2025?
Cash from operations of $295.4M minus capital expenditures of $160.5M left free cash flow of $134.9M.